Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care

Alderson, SL orcid.org/0000-0002-5418-0495, Wright-Hughes, A, Ford, AC orcid.org/0000-0001-6371-4359 et al. (20 more authors) (2022) Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care. Trials, 23 (1). 552. ISSN 1745-6215

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s) 2022. This is an open access article under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0)

Keywords: Irritable bowel syndrome, Amitriptyline, Primary care, Double-blind, Placebo, Randomised controlled tria
Dates:
  • Published: December 2022
  • Published (online): 8 July 2022
  • Accepted: 24 June 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds)
Funding Information:
Funder
Grant number
NIHR National Inst Health Research
16/162/01
Depositing User: Symplectic Publications
Date Deposited: 19 Jul 2022 09:59
Last Modified: 25 Jun 2023 23:02
Status: Published
Publisher: BMC
Identification Number: 10.1186/s13063-022-06492-6
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics